Genotype at the Secretor blood group locus is a determinant of plasma von Willebrand factor level

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 350-356

  Laffan, Michael A ^a   Manning, Richard A ^a   O'Donnell, James ^a   Boulton, Frank E ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Factor VIII; Lewis and Secretor blood groups; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLASMA FACTOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD GROUP ANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR VIII; GENOTYPE; HOMOZYGOTE; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; VON WILLEBRAND FACTOR;

EID: 0036182005     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03270.x     Document Type: Article

References (23)

1. DNA sequencing and screening for point mutations in the human Lewis (FUT3) gene enables molecular genotyping of the human Lewis blood group system
2. The effect of ABO blood group on the diagnosis of von Willebrand disease
3. Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults
4. Lewis histo-blood group system and associated Secretory phenotypes
5. Sequence and expression of a candidate for the human Secretor blood group α (1,2) fucosyltransferase gene (FUT2)
6. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
7. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4) fucosyltransferase
8. High plasma levels of Factor VIII and the risk of recurrent venous thromboembolism
9. Factor VIII levels and blood group antigens
10. Von Willebrand disease
11. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction
12. Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens
13. Influence of Lewis α1-3/4-L fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping and circulating tumor marker Sialyl-Lewis a levels
14. Possible effect of the Secretor locus on plasma concentration of factor VIII and von Willebrand factor
15. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
16. Von Willebrand factor
17. ABO blood group genotype and plasma von Willebrand factor in normal individuals
18. Secretor genotyping for A385T, G428A, C571T, C628T, 685delTGG, G849A and other mutations from a single PCR
19. Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and Secretor genotypes and evaluation of Secretor and Lewis genotyping in a Caucasian population
20. Kinetics of factor VIII-von Willebrand factor association
21. Factor VIII and von Willebrand factor
22. Biochemistry and genetics of the ABO. Lewis and P blood group systems
23. Molecular basis of antigenic specificity in the ABO. H and Lewis blood-group systems